LDL cholesterol target attainment in a representative German cohort of high- and very-high-CV risk patients with statin intolerance: a simulation study

被引：0
|
作者：
Katzmann, J. [1 ]
Stuerzebecher, P. E. [1 ]
Kruppert, S. [2 ]
Laufs, U. [1 ]
机构：
[1] Univ Hosp Leipzig AoR, Leipzig, Germany
[2] IQVIA, Frankfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Statin utilization and low-density lipoprotein cholesterol goal attainment in patients at very high cardiovascular risk: insights from a French general practice population
    Ferrieres, J.
    Steen, D. L.
    Sanchez, R.
    Chin, J.
    Gorcyca, K.
    Khan, I.
    EUROPEAN HEART JOURNAL, 2015, 36 : 288 - 288
  • [32] Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients
    Ray, K. K.
    Catapano, A. L.
    Diamand, F.
    Wolowacz, S.
    Haq, I.
    Bilitou, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2377 - 2377
  • [33] Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events
    Foley, KA
    Simpson, RJ
    Crouse, JR
    Weiss, TW
    Markson, LE
    Alexander, CM
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (01): : 79 - 81
  • [34] Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events
    Martin, RL
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (04): : 525 - 525
  • [35] LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF STATIN INTOLERANT PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY
    Gazzi, L.
    Fanelli, F.
    Heiman, F.
    Di Filippo, A.
    Pegoraro, V
    VALUE IN HEALTH, 2018, 21 : S96 - S96
  • [36] Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study
    Lehrke, Michael
    Vogt, Anja
    Schettler, Volker
    Girndt, Matthias
    Fraass, Uwe
    Tabbert-Zitzler, Anja
    Bridges, Ian
    Dhalwani, Nafeesa N.
    Ray, Kausik K.
    ADVANCES IN THERAPY, 2024, 41 (03) : 1184 - 1200
  • [37] Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study
    Michael Lehrke
    Anja Vogt
    Volker Schettler
    Matthias Girndt
    Uwe Fraass
    Anja Tabbert-Zitzler
    Ian Bridges
    Nafeesa N. Dhalwani
    Kausik K. Ray
    Advances in Therapy, 2024, 41 : 1184 - 1200
  • [38] LACKING OBSERVANCE OF THE GUIDELINES ON DYSLIPIDAEMIAS AS POSSIBLE REASON FOR LOW LDL-C GOAL ATTAINMENT IN PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK
    Mullerova, J.
    Vrablik, M.
    Sarkanova, I
    Brecikova, K.
    Tichopad, A.
    VALUE IN HEALTH, 2022, 25 (12) : S275 - S275
  • [39] TREATMENT PATTERNS AND LACK OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) GOAL ATTAINMENT AMONG HIGH-RISK PATIENTS USING HIGH OR MODERATE INTENSITY STATIN THERAPY IN GERMANY
    Fox, K. M.
    Fraass, U.
    Hatz, M.
    Qian, Y.
    Tai, M.
    VALUE IN HEALTH, 2017, 20 (09) : A603 - A603
  • [40] POOR ATTAINMENT OF LDL-CHOLESTEROL TARGET IN PATIENTS AT HIGH CARDIOVASCULAR RISK: A REPORT FROM THE ESC EORP EUROASPIRE V SURVEY IN 16 EUROPEAN COUNTRIES
    Kotseva, K.
    De Backer, G.
    De Bacquer, D.
    Ryden, L.
    Jennings, C.
    Wood, D.
    ATHEROSCLEROSIS, 2020, 315 : E81 - E81
12345